Raymond James & Associates’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$9.06M Sell
193,218
-334,167
-63% -$15.2M 0.01% 1284
2024
Q2
$22.3M Buy
527,385
+59,313
+13% +$2.6M 0.01% 722
2024
Q1
$20.7M Buy
468,072
+279,388
+148% +$12.7M 0.01% 764
2023
Q4
$8.69M Buy
188,684
+53,304
+39% +$2.27M 0.01% 1187
2023
Q3
$5.81M Buy
135,380
+31
+0% +$1.45K ﹤0.01% 1367
2023
Q2
$6.46M Buy
135,349
+553
+0.4% +$26.7K 0.01% 1320
2023
Q1
$6.56M Buy
134,796
+48,536
+56% +$2.47M 0.01% 1282
2022
Q4
$4.56M Buy
86,260
+37,079
+75% +$1.83M ﹤0.01% 1459
2022
Q3
$2.15M Sell
49,181
-6,233
-11% -$308K ﹤0.01% 1919
2022
Q2
$2.77M Buy
55,414
+9,910
+22% +$484K ﹤0.01% 1793
2022
Q1
$2.36M Buy
45,504
+6,146
+16% +$317K ﹤0.01% 2007
2021
Q4
$2.31M Buy
39,358
+12,088
+44% +$693K ﹤0.01% 2074
2021
Q3
$1.5M Sell
27,270
-670
-2% -$37.3K ﹤0.01% 2298
2021
Q2
$1.43M Sell
27,940
-78,712
-74% -$4.07M ﹤0.01% 2346
2021
Q1
$5.47M Buy
106,652
+25,917
+32% +$1.42M 0.01% 1371
2020
Q4
$4.47M Buy
+80,735
New +$4.31M ﹤0.01% 1404
2020
Q3
Sell
-79,633
Closed -$3.64M 3672
2020
Q2
$3.64M Sell
79,633
-9,043
-10% -$405K ﹤0.01% 1383
2020
Q1
$3.8M Sell
88,676
-82,326
-48% -$3.22M 0.01% 1195
2019
Q4
$6.19M Buy
+171,002
New +$6.36M 0.01% 1132

Other funds holding QGEN

Raymond James & Associates's QGEN Position: Q3 2024 in Review

Raymond James & Associates reduced its Qiagen (QGEN) stake by 63% in Q3 2024, selling an estimated $15.2M and leaving 193,218 shares worth $9.06M. The position accounts for 0.01% of the portfolio, ranked #1284.

Raymond James & Associates first reported a position in QGEN in Q4 2019 and has held it in 19 quarters since. The position peaked at $22.3M in Q2 2024. 329 funds tracked by Wall St. Rank hold QGEN as of Q3 2024.

  • Raymond James & Associates held 193,218 shares of Qiagen worth $9.06M as of Q3 2024.
  • Raymond James & Associates sold 334,167 Qiagen shares in Q3 2024, an estimated $15.2M.
  • Qiagen made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1284 holding.
  • Raymond James & Associates first reported a position in Qiagen in Q4 2019 and has held it in 19 quarters since.
  • Raymond James & Associates's Qiagen position peaked at $22.3M in Q2 2024.
  • 329 funds tracked by Wall St. Rank held Qiagen as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.